Biocompatibility and pharmacokinetic analysis of an intracameral polycaprolactone drug delivery implant for glaucoma

Kim J., Kudisch M., Mudumba S., Asada H., Aya-Shibuya E., Bhisitkul R.B., Desai T.A.

2016
Investigative Ophthalmology and Visual Science

View publication

Therapeutic Area

Glaucoma
Technology

Drug Delivery

Affiliations

San Francisco, CA, United States; Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, United States; Santen, Inc., Emeryville, CA, United States; Santen Pharmaceutical Co., Ltd., Nara RD Center, Nara, Japan; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, United States

Related Publications

Clinical outcomes of Preserflo MicroShunt implant procedure in open‑angle glaucoma patients – a 1000 eyes case-series; including subanalysis of combined cataract-glaucoma surgery and standalone surgery in pseudophakic eyes

Klabe, K.; Werth, J.P.; Kaymak, H. ; Fricke, A.

Müller glia derived EVs promote neurite recovery of an enriched population of retinal ganglion like cells derived from hESC retinal organoids after damage

Eastlake K, Lamb WDB, Tracey-White D, Shibagaki K, Khaw PT, Jayaram H, Limb GA

An Exploratory Study of Machine Learning-Based Open-Angle Glaucoma Detection Using Specific Autoantibodies

Takada N., Ishikawa M., Ninomiya T., Izumi Y., Sato K., Kunikata H., Yokoyama Y., Tsuda S., Fukuda E., Yamaguchi K., Ono C., Kirihara T., Shintani C., Hanyuda A., Goshima N., Zorumski C.F., NakazawaT.

View all Glaucoma publications